Xiaohui Ai Selected Research

aerolysin

3/2022	Sanguinarine Protects Channel Catfish against Aeromonas hydrophila Infection by Inhibiting Aerolysin and Biofilm Formation.
12/2021	Luteolin decreases the pathogenicity of Aeromonas hydrophila via inhibiting the activity of aerolysin.
4/2020	Thymol Protects Channel Catfish from Aeromonas hydrophila Infection by Inhibiting Aerolysin Expression and Biofilm Formation.
1/2018	Morin Protects Channel Catfish From Aeromonas hydrophila Infection by Blocking Aerolysin Activity.
11/2017	Magnolol protects channel catfish from Aeromonas hydrophila infection via inhibiting the expression of aerolysin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaohui Ai Research Topics

Disease

7	Infections 03/2022 - 01/2016
2	Body Weight (Weight, Body) 01/2021 - 04/2016
2	Bacterial Infections (Bacterial Infection) 04/2019 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2018
1	Hemolysis 12/2021
1	Communicable Diseases (Infectious Diseases) 04/2020
1	Virus Diseases (Viral Diseases) 01/2020
1	Inflammation (Inflammations) 01/2020
1	Neoplasms (Cancer) 01/2019
1	Animal Diseases 01/2014

Drug/Important Bio-Agent (IBA)

5	aerolysinIBA 03/2022 - 11/2017
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2016
2	Long Noncoding RNAIBA 01/2019 - 01/2018
1	sanguinarineIBA 03/2022
1	tiamulinIBA 01/2021
1	ThymolIBA 04/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2020
1	InterleukinsIBA 01/2020
1	Interleukin-22 (IL-22)IBA 01/2020
1	Subunit VaccinesIBA 04/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Copper Sulfate (Sulfate, Copper)FDA Link 12/2018
1	morinIBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	PorinsIBA 01/2018
1	AntigensIBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	magnololIBA 11/2017
1	BiofuelsIBA 01/2014

Therapy/Procedure

2	Oral Administration 01/2021 - 04/2016
1	Therapeutics 01/2019
1	Intravenous Administration 04/2016